Peroxisome Proliferator-Activated Receptor- As a Potential Therapeutic Target in the Treatment of Preeclampsia

Hypertension - United States
doi 10.1161/hypertensionaha.111.172627
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Peroxisome Proliferator-Activated Receptors as a Therapeutic Target in Asthma

PPAR Research
Drug DiscoveryPharmacology
2020English

Peroxisome Proliferator-Activated Receptor

English

Peroxisome Proliferator Activated Receptor

English

CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor in Human Liver

Molecular Pharmacology
Molecular MedicinePharmacology
2015English

Therapeutic Potential of Peroxisome Proliferator-Activated Receptor Modulation in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Nuclear Receptor Research
2017English

Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)

Science-Business eXchange
2009English

Characterization of the Fasting-Induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-Activated Receptor Target Gene

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2000English

Is Peroxisome Proliferator-Activated Receptor- A New "Pal" of Renin?

Hypertension
Internal Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy